Singapore, Jan 15, 2009: Japan\'s Takeda Pharmaceutical has appointed Mr Stefan Ziegler as CEO of Takeda Pharmaceuticals Asia (TPAsia), its wholly owned subsidiary for oversight of overall Asian sales and marketing. Mr Ziegler received a bachelor’s degree in Business administration with major in Finance and Marketing at University of Zurich in Switzerland and worked at Novartis from 1990 to 2008.
“We are excited to welcome Mr. Ziegler to Takeda,” said Mr Yasuchika Hasegawa, President of Takeda. “With many years of experience in the Asian pharmaceutical industry as an executive, we believe Mr Ziegler will bring a tremendous amount of perspective to Takeda in a pivotal position such as CEO of TPAsia.”
“I am very pleased to join Takeda, a growth oriented multinational pharmaceutical company and to accept this exciting challenge to lead TPAsia, which is a core organization for Takeda’s operations in Asia,” said Mr Stefan Ziegler. “Through new product introductions, innovative services and territorial expansion, I am determined to further enhance Takeda’s business foundation in Asia, a large geographical area with great business potential. It is my intension to do this in the spirit of Takeda’s business philosophy and by working closely with Takeda Head Quarter.”
TPAsia will supervise the overall business activities of Takeda’s sales and marketing subsidiaries in five Asian locations of Taiwan, Thailand, the Philippines, Indonesia and China, and will promote the optimal strategies centered on sales and marketing for the Asian region from medium and long-term perspectives.
Takeda is said to be aiming for the expansion of market share for each of the current Asian sales and marketing subsidiaries and for further entry into new markets through establishment of TPAsia, thereby realizing improved presence for Takeda in the Asian region.